RxDoctor Payments Data

Kellie Ohara

Nurse Practitioner · Denver, NCNPI 1316066079

Payments from drug & device makers

$461in general payments, 2019–2025

Across 27 payments — averaging $17.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$194
  • Pfizer$69
  • Novo Nordisk$62
  • Lilly USA, LLC$32
  • Exact Sciences$30
  • Masimo Corporation$22
  • plus $52 from 3 others

What the payments were for

  • Food & beverage$461100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$461 in reported general payments places this provider in the 65th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$39,067
Medicare patients
88
Services billed
474

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide17$20,283
JardianceEmpagliflozin23$20,132
MounjaroTirzepatide17$16,627
FarxigaDapagliflozin Propanediol11$16,453
Albuterol Sulfate HfaAlbuterol Sulfate44$1,396
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,297
Omeprazole36$681
Atorvastatin Calcium64$500
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$470
Bupropion XlBupropion Hcl19$433
Gabapentin33$380
Esomeprazole Magnesium17$373
Trazodone Hcl27$373
Cephalexin24$343
Pantoprazole Sodium32$285

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$62$20,28317 claims
Lilly USA, LLCMounjaro$32$16,62717 claims
AstraZenecaFarxiga$194$16,45311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Denver

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →